Naglaa M. Kamal

4PUBLICATIONS
13CO-AUTHORS
Neurosciences not elsewhere classifiedInfant and child healthNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 31, 2021
Nonsignificant trends in COVID-19 trials: Is there a significance?

Mostafa Yakoot

|Nov 24, 2019
Effects of sofosbuvir/ledipasvir therapy on chronic hepatitis C virus genotype 4, infected children of 3-6 years of age.

Enas M Kamal, Mortada El-Shabrawi, Hisham El-Khayat

|May 10, 2019
Serum Neuron-specific Enolase and S100 Calcium-binding Protein B in Pediatric Diabetic Ketoacidosis

Hatem Hamed Elshorbagy, Naglaa Fathy Barseem, Akram Elshafey Elsadek

|Apr 27, 2018
A pilot single arm observational study of sofosbuvir/ledipasvir (200 + 45 mg) in 6- to 12- year old children.

M H F El-Shabrawi, N M Kamal, H R El-Khayat

Pageof 1

Frequent Collaborators

2 joint publications

Enas M Kamal

1 joint publications

N M Kamal

1 joint publications

Dina Attia

1 joint publications

Hatem Hamed Elshorbagy